Bromocriptine mesylate

  Cat. No.:  DC23899   Featured
Chemical Structure
22260-51-1
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Bromocriptine (CB-154) is a dopamine D2 receptor agonist (Ki=3 nM) and and various serotonin receptors, also inhibits the release of glutamate by reversing the glutamate GLT1 transporter.
Cas No.: 22260-51-1
Chemical Name: Bromocriptine mesylate
Synonyms: Bromocriptine mesylate;2-Bromo-alpha-ergocryptine methanesulfonate;(+)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6'-18-trione methanesulfonate salt;2-Bromo α-Ergocryptine Mesylate;2-BroMo-α-ergocryptine Methanesulfonate salt;Bromocriptine (mesylate);Bromocriptine Methanesulphonate;CB-154;Bromocriptine mesilate;Parlodel;(+)-2-Bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)ergotaman-3′,6′-18-trione methanesulfonate salt;(+)-Bromocriptine methanesulfonate salt;Bromocriptine mesylate salt;CAS-22260-51-1;BROMOCRIPTINE MESILATE (MART.);CB 154 methanesulfonate (salt);2-Bromoergocryptine monomethanesulfonate (salt);BROMOCRIPTINE MESYLATE;Bromocriptine mesylate (USP);2-Bromo alpha-Ergocryptine Mesylate;Tox21_500171;SR-01000597796-1;DTXSID6020197;.alpha.-Ergocryptine, methanesulfonate;NCGC00260856-01;B 2134;2-Bromine-alpha-ergocryptine methanesulfonate;(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt);C32H40BrN5O5.CH3SO3H;D81822;Bromocriptine mesylate [USAN];2-Bromo-alpha-ergocryptine mesylate;BROMOCRIPTINEMESYLATE;BROMOCRIPTINE MESYLATE [USP-RS];BROMOCRIPTINE MESILATE (EP MONOGRAPH);ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULFONATE (SALT), (5'.ALPHA.)-;2-Bromoergocryptine Mesylate;2-Bromo-alpha-ergokryptine-mesilate;CCG-220121;Prestwick_771;22260-51-1;Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-;BROMOCRIPTINE MESYLATE [VANDF];BROMOCRIPTINE MESYLATE [USP MONOGRAPH];2-Bromo ?-Ergocryptine Mesylate;Cycloset;2-BROMOERGOCRYPTINE MONOMETHANESULPHONATE (SALT);HMS3712I04;Tox21_303597;CS-6048;Bromocriptine mesylate (USAN:USP);(+)-Bromocriptine methanesulfonate;SR-01000075356;AKOS015896276;2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate;BROMOCRIPTINE MESYLATE (USP MONOGRAPH);EU-0100171;Pravidel;NSC169774;BROMOCRIPTINE MESILATE [EP MONOGRAPH];NSC-755915;SR-01000597796;DTXCID00197;Bromocryptine methanesulfonate;ERGOTAMAN-3',6',18-TRIONE, 2-BROMO-12'-HYDROXY-2'-(1-METHYLETHYL)-5'-(2-METHYLPROPYL)-, MONOMETHANESULPHONATE (SALT), (5'alpha)-;BROMOCRIPTINE MESILATE [MART.];2-Bromo-alpha-ergokryptine-mesilate [German];BB164266;Q27105974;Bromocriptine mesilate (JP17);BROMOCRIPTINE MESILATE [WHO-DD];LP00171;BROMOCRIPTINE MESYLATE [ORANGE BOOK];Bromocriptine mesylate [USAN:USP];HMS3411K09;2-Bromo-.alpha.-ergocryptine monomethanesulfonate;EINECS 244-881-1;HB1813;HMS1568I04;Parlodel (TN);CHEMBL1200503;CCG-221475;NCGC00257268-01;Bromocryptine mesylate;Bagren;2-Bromo-a-ergocryptine methanesulfonate salt;Bromocriptine methanesulfonate;BROMOCRIPTINE MESILATE [JAN];SR-01000075356-1;Bromocriptine mesylate- Bio-X;Bromergon;alpha-Ergocryptine, 2-bromo-, methanesulfonate;NSC 7559...
SMILES: [H][C@@]12CC3=C(Br)NC4=CC=CC(C1=C[C@@H](C(N[C@@]5(C(C)C)C(N6[C@@H](CC(C)C)C(N7CCC[C@]7([C@]6(O)O5)[H])=O)=O)=O)CN2C)=C43.OS(=O)(C)=O
Formula: C32H40N5O5Br.CH4O3S
M.Wt: 750.700160000001
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Bromocriptine (CB-154) is a dopamine D2 receptor agonist (Ki=3 nM) and and various serotonin receptors, also inhibits the release of glutamate by reversing the glutamate GLT1 transporter; decreases body fat in animal and human models and increases lean muscle mass, improves glucose intolerance and insulin resistance, and reduces triglycerides and free fatty acids; also induces apoptosis and decreases colony formation in AML cells, shows synergy with standard agents and selectivity for the leukemic cell; reduces hyperphagia and adiposity in rats with diet-induced obesity.DiabetesApproved
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC74557 PREX-in1 PREX-in1 is a specific small-molecule inhibitor of P-Rex1 and P-Rex2 Rac-GEF activity with IC50 of 4.5 uM (P-Rex1 DHPH Rac-GEF activity) in liposome-based GEF assay, inhibits P-Rex1 and P-Rex2 through their catalytic DH domain.
DC74555 GYS32661 GYS32661 (GYS 32661) is a potent Rac inhibitor capable of inhibiting both Rac1 and Rac1b, inhibited activated Rac1 with IC50 of 1.18 uM in in vitro pull-down assays.
DC74539 L557-0155 L557-0155 is a small molecule inhibitor of VSIG-8, prevents VSIG-8 binding to VISTA, promotes cytokine production and cell proliferation in PBMCs and suppresses melanoma growth.
DC74528 K284 K284 is a selective small molecule inhibitor of chitinase 3 like1 (CHI3L1) with strong binding affinity (Kd=-9.7 kcal·mol-1), inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
DC74225 YB-537 YB-537 (YB537) is a potent, highly specific quinone reductase 2 (QR2) inhibitor with IC50 of 3 nM, shows no activity against QR1 (IC50>10 uM).
DC74223 X-Neu5Ac X-Neu5Ac (sodium) is a substrate for chromogenic assay of neuraminidase activity in bacterial expression systems; with a Km of 0.89 mM for neuraminidase.
DC74218 UT-59 UT-59 is a specific inhibitor of cholesterol-sensing membrane protein Scap, binds to Scap's cholesterol-binding site, blocks SREBP activation and inhibits lipid synthesis.
DC74205 Tryptolinamide Tryptolinamide (TLAM) is a small-molecule compound that activates mitochondrial respiration in cybrids generated from patient-derived mitochondria and fibroblasts from patient-derived iPSCs, inhibits phosphofructokinase-1 (PFK1) with an ATP-uncompetitive
DC74203 TR-107 TR-107 (TR107) is a highly potent, selective and orally bioavailable small-molecule activator of the mitochondrial protease ClpP with EC50 of 140 nM, binds to purified ClpP with Kd value of 180 nM in surface plasmon resonance (SPR) measurement.
X